Biological data continues to grow in volume, variety and complexity but largely remains underutilized. Use the power of our AI-enabled platform and our team of experts to look through more data than ever before and discover assets.
Proprietary AI-powered frameworks to mine big data and accelerate target discovery across indications.
Uncover novel mechanisms of action in drug discovery using the power of integrative omics.
Identify clinically relevant biomarkers using integrated biomedical data.
Move beyond singular mutation studies to patient stratification focused on novel gene signatures.
Integrative Omics powered approaches to identifying potent, selective lead compounds.
A proprietary approach to identification of gene-disease correlations for drug discovery.
ASSETS DISCOVERED
PARTNERSHIPS ACROSS 10+INDICATIONS
PUBLICATIONS
Our Sales team will give you a live demo of all features
If you are a researcher – Experience it for free, If you work in industry – We have attractive pricing
Speak with our Sales team to identify the best offering for your use case and to know more about our pricing